✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Wcn265407PharmacokineticsCannabidiol Why This MattersThis item covers developments relevant to cannabis medicine and clinical practice....
23rd State Sets New Performance Standard for THC Beverages with Cohort 2 Results from …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic EdiblesPharmacokineticsDosingRegulationProduct Safety Why This MattersTHC beverage formulations represent a rapidly evolving delivery method with...
Ditch the Beer: Cycling Frog’s THC Drinks and Gummies Hit Different – VICE
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic EdiblesDosingAlcohol AlternativePatient EducationPharmacokinetics Why This MattersThe emergence of standardized THC beverages represents a significant...
Cannabinoids and drug-drug pharmacokinetic interactions: Deciphering the risks.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemica…
Marijuana leaf, vapes available to medical cannabis patients under new bill – Yahoo
✦ New CED Clinical Relevance #84High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Delivery MethodsPolicyVaporizationPharmacokineticsPatient Access Why This MattersExpanded product availability gives clinicians more dosing options...
Inside the FIRST Controlled Cannabis Airflow Trial with Dr. Allison Justice – YouTube
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic InhalationDosingPharmacokineticsClinical ResearchDrug Delivery Why This MattersControlled airflow studies represent a critical step toward...
Nexalis (formerly InhaleRx) initiates Phase 1 trial of IRX-616a CBD MDI – OINDP News
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic CbdDrug DeliveryPharmacokineticsClinical TrialsRespiratory Why This MattersThe development of a metered-dose inhaler (MDI) for...
Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and Permeation Enhancement.
Cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC) have garnered significant interest for their broad-spectrum pharmacological activity in…
Results of an Exploratory Crossover Pharmacokinetic Study Evaluating a Natural Hemp Extract-Based Cosmetic Product: Comparison of Topical and Oral Routes of Administration.
CED Clinical Relevance #50Monitored Relevance Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch | CED Clinic TopicalHempPharmacokineticsBioavailabilityCosmetic JournalPharmaceuticals (Basel, Switzerland)Study TypeClinical StudyPopulationHuman participants Why This MattersThis crossover pharmacokinetic study provides much-needed data...